Use of Oral Contraceptives for Management of Acne Vulgaris Practical Considerations in Real World Practice

被引：11
|
作者：
Harper, Julie C. [1 ]
机构：
[1] Dermatol & Skin Care Ctr Birmingham, 2470 Rocky Ridge Rd, Birmingham, AL 35243 USA
来源：
DERMATOLOGIC CLINICS | 2016年 / 34卷 / 02期
关键词：
Acne vulgaris; Hormones; Oral contraceptives; Hyperandrogenism; COMBINED HORMONAL CONTRACEPTIVES; COLLABORATIVE REANALYSIS; VENOUS THROMBOEMBOLISM; ETHINYL ESTRADIOL; HEALTH-BENEFITS; INDIVIDUAL DATA; LESION COUNTS; DOUBLE-BLIND; DROSPIRENONE; BREAST;
D O I：
10.1016/j.det.2015.11.005
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Acne vulgaris may be effectively treated with combination oral contraceptive pills (COCs) in women. COCs may be useful in any woman with acne in the absence of known contraindications. When prescribing a COC to a woman who also desires contraception, the risks of the COC are compared with the risks associated with pregnancy. When prescribing a COC to a woman who does not desire contraception, the risks of the COC must be weighed against the risks associated with acne. COCs may take 3 cycles of use to show an effect in acne lesion count reductions.
引用
收藏
页码：159 / +
页数：8
相关论文
共 50 条
  • [41] Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting
    Riess, Hanno
    Ay, Cihan
    Bauersachs, Rupert
    Becattini, Cecilia
    Beyer-Westendorf, Jan
    Cajfinger, Francis
    Chau, Ian
    Cohen, Alexander T.
    Khorana, Alok A.
    Maraveyas, Anthony
    Renni, Marcos
    Young, Annie M.
    ONCOLOGIST, 2018, 23 (07): : 822 - 839
  • [42] Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne
    Barbieri, John S.
    Choi, Juliana K.
    James, William D.
    Margolis, David J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (03) : 848 - 851
  • [43] ORAL TRIMETHOPRIM AS A 3RD-LINE ANTIBIOTIC IN THE MANAGEMENT OF ACNE-VULGARIS
    BOTTOMLEY, WW
    CUNLIFFE, WJ
    DERMATOLOGY, 1993, 187 (03) : 193 - 196
  • [44] Oral contraceptives and MS disease activity in a contemporary real-world cohort
    Bove, Riley
    Rankin, Kelsey
    Chua, Alicia S.
    Saraceno, Taylor
    Sattarnezhad, Neda
    Greeke, Emily
    Stuart, Fiona
    LaRussa, Allison
    Glanz, Bonnie I.
    Chitnis, Tanuja
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : 227 - 230
  • [45] Oral contraceptives and MS disease activity in a modern real-world cohort
    Bove, R.
    Rankin, K.
    Chua, A. S.
    Saraceno, T.
    Sattarnezhad, N.
    Greeke, E.
    Stuart, F.
    LaRussa, A.
    Glanz, B. I.
    Healy, B. C.
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 119 - 120
  • [46] Use of topical retinoids by dermatologists and non-dermatologists in the management of acne vulgaris
    Pena, Sandra
    Hill, Dane
    Feldman, Steven R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (06) : 1252 - 1254
  • [47] Practical considerations for the use of direct oral anticoagulants in oncology patients
    Duong, Arianne
    Sing, Sarah
    Taketa, Cathy
    Miske, Abby
    Segal, Eve
    Garcia, David
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (03) : 692 - 702
  • [48] Carboxytherapy in management of acne flare in patients with moderate to severe acne vulgaris under treatment with oral isotretinoin: a case series
    Bagherani, Nooshin
    Mirmomeni, Golshan
    Smoller, Bruce R.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [49] Practical Considerations for the Use of Subcutaneous Treatment in the Management of Dyslipidaemia
    Franck Boccara
    Ricardo Dent
    Luis Ruilope
    Paul Valensi
    Advances in Therapy, 2017, 34 : 1876 - 1896
  • [50] Practical Considerations for the Use of Subcutaneous Treatment in the Management of Dyslipidaemia
    Boccara, Franck
    Dent, Ricardo
    Ruilope, Luis
    Valensi, Paul
    ADVANCES IN THERAPY, 2017, 34 (08) : 1876 - 1896
12345